Area of research
Infectious Diseases · Animal Science and Zoology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Viral gastroenteritis research and epidemiology, and COVID-19 Clinical Research Studies.
A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification
Neutralization, effector function and immune imprinting of Omicron variants
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Broad betacoronavirus neutralization by a stem helix–specific human antibody
Broad sarbecovirus neutralization by a human monoclonal antibody
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms